Follicular Lymphoma
News
Lymphocyte, monocyte data can predict treatment response in follicular lymphoma
Blood cell count values at diagnosis can predict the clinical outcomes in follicular lymphoma.
News
Follicular lymphoma treatment can benefit patients 80 years and older
FL-directed therapy was associated with an overall survival benefit, which persisted.
News
Adding lymphopenia component ‘improves’ FLIPI
The FLIPI-L could better predict survival and histologic transformation, when compared with the original FLIPI.
Conference Coverage
REGN1979 shows good activity in pretreated aggressive B-NHL
...
Conference Coverage
Survival data reported from largest CAR T trial in B-cell lymphoma
ORLANDO – Progression-free survival results were best among complete responders and patients with primary mediastinal large B-cell lymphoma or...
Opinion
New evidence informs discussions on FL treatment and breast screening
Dr. Alan P. Lyss explores recent studies on rituximab maintenance in follicular lymphoma and the use of MRI as a supplemental screening for women...
News
Newly identified genetic changes contribute to transformation of follicular lymphoma
The case of a 36-year-old man whose low-grade follicular lymphoma transformed to B-ALL/LBL about 1 year after diagnosis sheds lights on the...
News
Rituximab maintenance has a durable benefit in follicular lymphoma
At a median of 9 years of follow-up, progression-free survival was extended versus observation but there was no difference in overall survival.
Conference Coverage
Armored CAR T cells elicit responses in NHL patients
NATIONAL HARBOR, MD. – ICTCAR014, a dominant negative PD-1 armored CAR T-cell therapy, produced responses in 12 of 13 non-Hodgkin lymphoma...
News
Best treatment approach for early stage follicular lymphoma is unclear
Overall survival rates were similar with different treatment approaches, including watchful waiting.